Atlas Trials

Colistin and Meropenem Versus Amikacin and Meropenem for MDR Gram Negative Bacteria Regarding Efficacy and Safety.

Clinical trial NCT07694700 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT07694700
Sponsor
Beni-Suef University
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
MDR Bacteria
Start date
2025-12-30
Primary completion
2026-08-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.